Ngā hua rapu - Emmanuel Blot

  • E whakaatu ana i te 1 - 7 hua o te 7
Whakamahine hua
  1. 1
    Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: Results of the randomised GEFCAPI 02 trial

    Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: Results of the randomised GEFCAPI 02 trial mā Marine Gross‐Goupil, A. Fourcade, Emmanuel Blot, Nicolas Penel, Sylvie Négrier, Stéphane Culine, L. Chaigneau, Thierry Lesimple, Franck Priou, Alain Lortholary, Marie‐Christine Kaminsky, J. Provençal, Éric Voog, J. Bouzy, A. Laplanche, Karim Fizazi

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    RETRACTED: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

    RETRACTED: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial mā Hervé Bonnefoi, Anil Potti, Mauro Delorenzi, L. Mauriac, Mario Campone, M. Tubiana-Hulin, Thierry Petit, Philippe Rouanet, Jacek Jassem, Emmanuel Blot, Véronique Becette, Pierre Farmer, Sylvie André, Chaitanya R. Acharya, Sayan Mukherjee, David Cameron, Jonas Bergh, Joseph R. Nevins, Richard Iggo

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial

    TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial mā Hervé Bonnefoi, Martine Piccart, Jan Bogaerts, L. Mauriac, P. Fumoleau, Étienne Brain, Thierry Petit, Philippe Rouanet, Jacek Jassem, Emmanuel Blot, Khalil Zaman, Tanja Čufer, Alain Lortholary, Elisabet Lidbrink, Sylvie André, Saskia Litière, Lissandra Dal Lago, Véronique Becette, David Cameron, Jonas Bergh, Richard Iggo

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study

    Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study mā Jean Louis Lefèbvre, Y. Pointreau, Frédéric Rolland, M. Alfonsi, A Baudoux, C. Sire, D. De Raucourt, O. Malard, M. Degardin, C. Tuchais, Emmanuel Blot, M. Rives, Émile Reyt, Jean Marc Tourani, L. Geoffrois, Fréderic Peyrade, F. Guichard, Dominique Chevalier, E. Babin, Philippe Lang, François Janot, G. Calais, P. Garaud, É. Bardet

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial

    Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label,... mā J. Guigay, Cécile Ortholan, Damien Vansteene, Didier Cupissol, Caroline Even, Marie‐Christine Kaminsky, C. Sire, Emmanuel Blot, P. Debourdeau, Laurence Bozec, Esma Saâda-Bouzid, Jérôme Fayette, Pierre Dalloz, Y. Pointreau, H. Le Caer, Claire Falandry, Laurence Digue, A. Braccini, S. López, Pierre Guillet, Cécile Michel, Nadir Cheurfa, Dominique Schwob, Jean Bourhis, C. Mertens, Anne Aupérin

    I whakaputaina 2024
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study

    Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study mā Hugues Bourgeois, Françoise Grudé, P. Solal-Céligny, Olivier Dupuis, Éric Voog, G. Ganem, Fabrice Denis, M. Zinger, Laurence Juhel-Voog, C. Lafond, P. Maillart, Olivier Capitain, R. Delva, P Soulié, Sophie Abadie‐Lacourtoisie, Véronique Guerin‐Meyer, Marie-Emmanuelle Morin-Meschin, Jean‐Marie Commer, A. Gangler, Bénédicte d’Aillières, Alain Zannetti, Emmanuelle Bourbouloux, D. Berton-Rigault, Sophie Lebouvier-Sadot, Mehdi Kaassis, J Baudon, You Heng Lam, A. Bizieux, M. Marcq, Julien Edeline, Fanny Le Du, Claudia Lefeuvre, Philippe Deguiral, Valérie Delecroix, Emmanuel Blot, Joëlle Egreteau, M.-J. Goudier, R. Lamy, Marc Ferec, Xavier Artignan, Stéphane Corbinais, Hugues Morel, Anne Claire Hardy-Bessard, Caroline Alleaume, Emmanuel Naudeix, Oana Cojocarasu, Jean‐Philippe Metges, C. Riché, Érick Gamelin, Delphine Déniel-Lagadec, Fanny Marhuenda, Pierre Ingrand, Jean‐Yves Douillard

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

    Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcin... mā J. Guigay, Anne Aupérin, Jérôme Fayette, Esma Saâda-Bouzid, Cédrik Lafond, Miren Taberna, Lionnel Geoffrois, Laurent Martin, Olivier Capitain, Didier Cupissol, Hélène Castanie, Damien Vansteene, Philippe Schafhausen, Alison Johnson, Caroline Even, Christian Sire, Sophie Duplomb, Camille Evrard, Jean‐Pierre Delord, Brigitte Laguerre, Sylvie Zanetta, Cécile Chevassus-Clément, Aldéric Fraslin, Fanny Louat, Laura Sinigaglia, Ulrich Keilholz, Jean Bourhis, Ricard Mesı́a, Nabil Baba-Hamed, E. Babin, G. Béra, Sarah BETRIAN-LAGARDE, Emmanuel Blot, Emmanuelle Bompas, Christian Borel, Mohamed BOUCHEKOUA, L. Bozec Le Moal, Amandine Bruyas, G. Calais, Ioana Carpiuc, S. Chapet, Thierry Chatellier, Bruno Chauffert, Sandrine Pacquelet, Florian Clatot, Oana Zveltlana Cojocarasu, Alexandre CORNELLY, Alexandre Coutté, Pierre Dalloz, Franck Darloy, Melissa Delhommeau, D. De Raucourt, C. Debelleix, P. Debourdeau, Anne Françoise DILLIES-LEGRAIN, Pascal Dô, Catherine Dubos‐Arvis, Agnès Ducoulombier, Claude El Kouri, Sabrina Falkowski, François‐Régis Ferrand, Michel Gatineau, Radj Gervais, L. Gras, Pierre Guillet, Ali Hasbini, Stéphane HENAULT, Ruth Gabriela Herrera Gómez, F. Huguet, Marie Christine Kaminsky, Aurélie Lagrange, Sandrine Lavau‐Denès, H. Le Caer, Christine Le Foll, G. Lefebvre, B. Linot, Qian LOPEZ, Alain Lortholary, Margarida Matias, L. Mayache-Badis, Floriane Minne, Delphine Mollon, Eve Marie Neidhardt, J. Pavillet, Fréderic Peyrade, Yohann POINTREAU, Jean‐François Ramée, Camille RAUCHE, Sandrine Richard, Claudia Rizzo, Frédéric Rolland, Friderike SCHLURMANN, Laëtitia Stefani, Louis Tassy, Youssef Tazi, Jean‐Christophe Théry, Florida TORTI EL ZEIN, C. Toullec, Jean‐Marc Tourani, Philippe Toussaint

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: